NCC AB (publ) (NCC-A)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 182.00 |
|---|---|
| 52-week range | 167.50 – 242.00 |
| Return, 1 month / 3 months | +1.4% / +6.7% |
| Return, 1 year / 3 years | −14.6% / +88.9% |
| Trend | Below its 200-day average |
| RSI (14) | 57 |
| Volatility (1 year) | 32.2% |
| Worst drawdown (1 year) | -27.8% |
| Average daily value traded | 0.86M SEK |
| Dividend yield | 6.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NCC is a Swedish construction and property development group based in Solna. It builds and renovates housing, offices, schools and other buildings, and carries out civil engineering work such as roads, bridges, tunnels and water infrastructure. The company also produces asphalt and stone materials and develops residential and commercial property. Its customers are mainly public authorities, municipalities, property owners and industrial clients, chiefly in the Nordic region.
The shares are listed on the Nasdaq Stockholm in Sweden under the code NCC-A, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NCC AB (publ) (NCC-A) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 182.00 on 27 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 319 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.6% and over the last three months it rose 6.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.7% | ||
| From 52-week high | -24.8% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.7% | ||
| 6-month return | -12.9% | ||
| 12-month return, skipping the last month | -15.8% | ||
| Stability (higher is calmer) | 74 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.8% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.86M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 90 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.0% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | +3.4% |
|---|---|
| 1 month | +1.4% |
| 3 months | +6.7% |
| 6 months | −12.9% |
| 1 year | −14.6% |
| 3 years | +88.9% |
| 5 years | +58.9% |
Signals
| 50-day / 200-day average | 178.07 / 193.06 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.06 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 May 2026 | SEK 6.5000 |
| 6 Nov 2025 | SEK 4.5000 |
| 8 May 2025 | SEK 6.5000 |
| 6 Nov 2024 | SEK 4.0000 |
| 10 Apr 2024 | SEK 4.0000 |
| 3 Nov 2023 | SEK 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.